From COVID to cancer: Why Canada’s RNA vaccine leadership matters more than ever
By Anna Blakney, Assistant Professor, Michael Smith Laboratories and School of Biomedical Engineering, University of British Columbia
Pieter Cullis, Professor, Biochemistry and Molecular Biology, Faculty of Medicine, University of British Columbia
Research teams across Canada are now building on homegrown innovation to expand the potential of RNA vaccines beyond infectious diseases.
Read complete article
© The Conversation
-
Wednesday, April 30, 2025